Skip to content

Clinical trials

Recruiting Phase 2 Alzheimer Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Phase 2 Status: Recruiting Clear all

54 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20182
20201
20213
20224
20234
20248
202520
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting54

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sunnybrook Health Sciences Centre3
Bernard (Barry) Baumel2
Rutgers, The State University of New Jersey2
University of Colorado, Denver2
University of Minnesota2
Akiva Mintz1
Amydis Inc.1
Brigham and Women's Hospital1
Celgene1
Chang Gung Memorial Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease54
Cognitive Dysfunction22
Dementia12
Nervous System Diseases4
Brain Diseases3
Neurocognitive Disorders3
Psychomotor Agitation3
Sleep Initiation and Maintenance Disorders3
Central Nervous System Diseases2
Mental Disorders2

Trials

Showing 1 to 25 of 54. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.